ContraFect starts common stock offering
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Yonkers, N.Y.-based ContraFect Corp. launched an underwritten public offering for its common stock.
All shares in the offering will be sold by the clinical-stage biotechnology company.
Piper Jaffray & Co. and William Blair & Co. LLC are acting as joint book-running managers for the offering.
